Home Top Movers Is Check Cap Ltd (CHEK) Stock a buy now?

Is Check Cap Ltd (CHEK) Stock a buy now?

Things have started to change for Check Cap since the NASDAQ compliance re-gain extension. 

The clinical-stage medical diagnostics company shares are trading with strong momentum. The average trading volume of Check-Cap Ltd. (CHEK) is just over 8 million. As we write this on Jan 5., the trading volume is almost 235 million. Is it a good time to jump in and buy the stock?


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


What going on?

Check-Cap Ltd. (CHEK) stock is skyrocketing, but what’s the exact reason? On Dec. 30, 2020, the company received a notice of a 180-day extension to regain NASDAQ compliance. This allows the stocks to have enough time to trade above the $1 minimum required share price on the market. 

This NASDAQ compliance extension has driven high volume over the past week. Investors are now seeing things in a positive way as the company tries to fight back.

Back in Nov. 2020, the company announced that it had submitted the Investigational Device Exemption (IDE) application to the FDS for its pivotal study of C-Scan. The IDE is a great achievement towards the initiation of the pivotal study in the U.S. The company is expected to provide updates on its C-Scan study in the near future, following the guidance from the FDA. 

Moreover, the company is preparing well at the backend for the U.S. pivotal study; improving the supply chain, quality controls, and device manufacturing. The company is also managing the expansion of this study at the leading Israeli sites. 

The core objective of Check-Cap is to advance its C-Scan towards the final cynical stages and make it to the market. The C-Scan is being developed as a patient-friendly colorectal cancer (CRC) screening option—detecting pre-cancerous polyps. The company expects a response from the FDA anytime soon.

However, on the other side of the picture, there are concerns regarding Check-Cap’s cash balance. As of Sep. 2020, the company had cash of $21 million with zero debt. Essentially, the cash burn was almost $13 million over the past twelve months. With that, the company had only 19 months of cash runway. The worrying part is that if the company runs out of cash, and that too in the middle of a pandemic. 

Check-cap is still in its early days and is developing as a business. The increase in cash burn shows that the company is focused on future growth and its current focus on its C-Scan pivotal study. 

Conclusion

Wall Street is positive on Check-Cap Ltd. (CHEK) and expects medical diagnostics to grow in the long-term. The game will change once the company receives the guidance update from the FDA on IDE. However, analysts’ rate CHEK stock as a strong buy. The average price target is around $1.7, with an upside of 32% over the next 12 months.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

What Drove The STRATA Skin Sciences, Inc. (NASDAQ: SSKN) Stock In Extended Trading?

Shares of dermatology-focused company STRATA Skin Sciences, Inc. (NASDAQ: SSKN) leapt 15.03% to $1.99 in the trading after ring of the bell on Monday....

Why Sundial Growers (SNDL) shares have skyrocketed in intraday trading?

Shares of Sundial Growers (SNDL) have been on a skywalk. As of 10:47 AM EST, the seller, and producer of Cannabis products recorded $1.38...

What Caused 35% Pre-Market Surge In electroCore, Inc. (ECOR) Stock Today?

Shares of electroCore, Inc. (ECOR) has been surging strongly in the pre-market session today following an announcement of exclusive distribution agreement in Australia. The...

Zix Corp (ZIXI) Stock Surged 7% After-Hour For What Reason?

The stock of email security solution provider Zix Corp (ZIXI) has added 7.05% to its value in the after-hours trading on Friday. The company...

Apple Inc. (AAPL) Stocks dip but future prospects for the company seem very positive

On Thursday, Apple shares (NASDAQ: AAPL) closed at $120.99 which is 3.5% lower. In the after-hours session, the price further declined by 0.2%.  The...

Why there is an uncertainty around Palantir Technologies Inc (PLTR)?

Palantir Technologies Inc (PLTR)‎ is a public American software company that specializes in big data analytics. The company has shown a recovery in its...

Here’s What You Should Know About Just Energy Group Inc (JE) Stock

Just Energy Group Inc (JE)‎ stock has shown a rise in the last trading session. JE is a natural gas and electricity retailer based...

ASLAN Pharmaceuticals (ASLN) Stock sees 70% stock price increase due to successful first trial report

ASLAN Pharmaceuticals (NASDAQ: ASLN) moved upward an impressive 73.58% and has reached a share price of $7.69. ASLAN had previously closed at $4.43. This...

Related News

Why there is an uncertainty around Palantir Technologies Inc (PLTR)?

Palantir Technologies Inc (PLTR)‎ is a public American software company that specializes in big data analytics. The company has shown a recovery in its...

What’s Bringing The Fibrogen (FGEN) Stock Down 23% Pre-Market Today?

The biopharmaceutical company FibroGen, Inc. (FGEN) has been seeing its stock’s price falling 23.81% in pre-market trading today. The decline came following sharing of...

Why The9 Limited (NCTY) Took A 12.64% Leap After-Hours?

Shares of the China based internet company The9 Limited (NCTY) leapt 12.64% in extended trading on Monday. In the absence of any significant news,...

What Pushed Inuvo Inc (INUV) Stock Up 25% After-Hours On Monday?

Shares of the technology company Inuvo, Inc (INUV) raised 34.35% in the after-hours trading on Monday. The company saw its stock price climbing 23.58%...

Shares of SOS Limited (SOS) are soaring. What’s Going on?

SOS Limited (SOS), an emerging blockchain-based company in China, is soaring in current-market trading after facing a decline of 21% in the previous open...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.